Indeed, the expression of SGLT2 mRNA and protein in cardiomyocytes from end-stage failing heart and its overexpression in diabetic cardiomyocytes suggest that SGLT2 may be implicated in the pathogenesis of HF including cardiac steatosis. The gene discussed is SLC5A2; the disease is hydrops fetalis.